ClinicalTrials.gg
DrugBiological

Tositumomab I-131 clinical trials

Also written Iodine-131 Anti-B1 Antibody and Bexxar.

studies test it
24
open now
0
in phase 3
1
first study started
1995

How each study uses tositumomab I-131 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

Bexxar
4

Other names

Iodine-131 Anti-B1 Antibody
7
Iodine I 131 Tositumomab
2

In one entry with another drug

Given together, or one or the other

Tositumomab and Iodine I 131 Tositumomab
5
Bexxar Therapeutic Regimen
2

Studies by the year they started

22 studies that test it; most in 2007 (5)

Studies that test tositumomab I-131, by start year
YearStudies
19951
19962
19984
19993
20002
20011
20031
20042
20051
20075

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
17
Phase 3
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 7

GlaxoSmithKline (11) · Corixa Corporation (6) · University of Michigan Rogel Cancer Center (1) · Fred Hutchinson Cancer Center (1) · Susan Knox (1) · University of Pennsylvania (1) · Rush University Medical Center (1) · Stanford University (1)

Often tested with

Tested in the same studies.

Tositumomab (10) · Bortezomib (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses tositumomab I-131 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test tositumomab I-131 →

Given beside what is tested · 1 — tositumomab I-131 is usual care or a partner of the new treatment

Codes

What other systems call tositumomab I-131 · ClinicalTrials.gg INT004159

  • MeSH (NLM) C119496tositumomab I-131Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) K1KT5M40JCTOSITUMOMAB I-131Confirmed FDA, NLM
  • RxNorm 234449One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.